The Effects of Miminal Stimulation Protocol on Preimplantation Genetic Screening
NCT ID: NCT05220995
Last Updated: 2022-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2021-05-15
2022-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PGT-A Versus Blastocyst Morphology Selection
NCT03095053
Whole Genome Sequencing (WGS) on IVF Embryos and Individual Patients
NCT05739890
Noninvasive Chromosomal Screening for Embryo Selection Trial
NCT04732013
Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection
NCT05545995
PGS Using Microarray in IVF Patients With Repeated Implantation Failure
NCT02265614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
100 patients with minimal
In advancing maternal age (AMA) women, minimal stimulation protocol (MSP) with the new combination of human menopausal gonadotrophin (hMG) and clomiphene citrate (CC) were performed for controlled ovarian hyperstimulation is defined for poor ovarian response women.
protocol
ovarian stimulation protocols on euploid rates were compared.
100 patients with recombinant FSH antagonist protocol
In advancing maternal age (AMA) women, flexible antagonist protocol with recombinant FSH were performed for controlled ovarian hyperstimulation is defined for poor ovarian response women.
protocol
ovarian stimulation protocols on euploid rates were compared.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
protocol
ovarian stimulation protocols on euploid rates were compared.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
38 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gokalp Oner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gokalp Oner
Adem Yavuz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gokalp Oner
Kayseri, Gevher Nesibe, Turkey (Türkiye)
Gokalp Oner
Kayseri, Gevher Nesibe, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31.01.2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.